Header cover image

U.K. (FTSE) Clinical Research and Equipment Industry Analysis

UpdatedMay 29, 2025
DataAggregated Company Financials
Companies9
  • 7D-1.1%
  • 3M1.2%
  • 1Y-13.6%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.1%, driven by a pullback from hVIVO of 7.0%. The industry has fallen 14% in the last year. Looking forward, earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 29 May 2025UK£1.6bUK£319.6m-UK£190,979,785.0010.2x-8.5x5.1x
Sat, 26 Apr 2025UK£1.6bUK£313.9m-UK£192,362,214.3510.9x-8.4x5.1x
Mon, 24 Mar 2025UK£1.6bUK£315.6m-UK£186,234,564.206x-8.5x5x
Wed, 19 Feb 2025UK£1.8bUK£306.5m-UK£195,180,498.487x-9.4x6x
Fri, 17 Jan 2025UK£2.1bUK£307.6m-UK£196,033,516.807.1x-10.7x6.8x
Sun, 15 Dec 2024UK£2.1bUK£306.4m-UK£195,163,702.568.5x-10.8x6.9x
Tue, 12 Nov 2024UK£1.9bUK£305.1m-UK£193,004,299.1211.1x-10x6.3x
Thu, 10 Oct 2024UK£2.0bUK£304.4m-UK£192,350,536.9010.3x-10.6x6.7x
Sat, 07 Sep 2024UK£2.0bUK£293.4m-UK£192,317,721.9012.2x-10.4x6.8x
Mon, 05 Aug 2024UK£1.8bUK£295.5m-UK£189,945,748.2312.6x-9.7x6.2x
Wed, 03 Jul 2024UK£1.5bUK£295.9m-UK£190,219,269.3911.5x-7.9x5.1x
Fri, 31 May 2024UK£1.6bUK£295.6m-UK£189,825,740.0411.3x-8.5x5.5x
Sun, 28 Apr 2024UK£1.5bUK£292.9m-UK£189,020,345.457254.7x-7.7x5x
Tue, 26 Mar 2024UK£1.8bUK£295.9m-UK£213,186,589.217352.9x-8.3x6x
Thu, 22 Feb 2024UK£1.9bUK£285.9m-UK£189,294,445.636961.7x-9.9x6.6x
Sat, 20 Jan 2024UK£2.9bUK£450.2m-UK£176,590,140.0062.1x-16.2x6.4x
Mon, 18 Dec 2023UK£3.1bUK£450.1m-UK£174,093,562.0054.8x-17.6x6.8x
Wed, 15 Nov 2023UK£3.0bUK£455.7m-UK£168,812,508.0048.6x-17.9x6.6x
Fri, 13 Oct 2023UK£3.0bUK£458.6m-UK£165,609,758.0052.7x-18x6.5x
Sun, 10 Sep 2023UK£3.1bUK£440.5m-UK£166,985,165.0069.6x-18.6x7x
Tue, 08 Aug 2023UK£3.4bUK£476.5m-UK£124,657,875.0070.6x-27x7.1x
Thu, 06 Jul 2023UK£2.9bUK£476.6m-UK£124,781,543.0066.1x-23.6x6.2x
Sat, 03 Jun 2023UK£3.3bUK£476.9m-UK£116,967,761.0067.8x-28.4x7x
Mon, 01 May 2023UK£3.1bUK£479.9m-UK£117,165,188.0036.3x-26.8x6.5x
Wed, 29 Mar 2023UK£2.7bUK£459.0m-UK£119,147,500.0033.4x-22.8x5.9x
Fri, 24 Feb 2023UK£3.2bUK£443.8m-UK£183,166,505.0044.1x-17.2x7.1x
Sun, 22 Jan 2023UK£3.4bUK£442.7m-UK£182,486,738.0047.5x-18.6x7.7x
Tue, 20 Dec 2022UK£3.4bUK£443.3m-UK£182,823,312.0048.3x-18.3x7.6x
Thu, 17 Nov 2022UK£3.8bUK£447.6m-UK£178,735,500.0050.2x-21x8.4x
Sat, 15 Oct 2022UK£67.9bUK£449.2m-UK£176,568,208.0042.7x-384.3x151x
Mon, 12 Sep 2022UK£3.8bUK£366.0m-UK£191,147,579.0047.3x-20x10.5x
Wed, 10 Aug 2022UK£3.9bUK£366.6m-UK£188,072,427.0047.7x-20.7x10.6x
Fri, 08 Jul 2022UK£3.8bUK£366.8m-UK£188,165,802.0041.2x-20.4x10.5x
Sun, 05 Jun 2022UK£3.8bUK£360.3m-UK£192,190,085.0043x-19.9x10.6x
Price to Earnings Ratio

-19.9x


Total Market Cap: UK£3.8bTotal Earnings: -UK£192,190,085.00Total Revenue: UK£360.3mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Clinical Research and Equipment Industry Price to Earnings3Y Average -18.6x202320242025
Current Industry PE
  • Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 8.0x is higher than the industry's current PS ratio of 5.1x.
Past Earnings Growth
  • Losses for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have declined 3.9% per year.
  • This means that the cost of doing business could be reducing since sales have declined but losses haven't fallen much further.

Industry Comparison

How does U.K. Clinical Research and Equipment compare with similar industries?

GB Market-0.76%
Healthcare-0.30%
Life Sciences-1.12%
Clinical Research and Equipment-1.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FAB Fusion AntibodiesUK£0.0661.6%
+UK£113.7k
72.4%PS4.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IXI

UK£0.12

IXICO

7D

-1.6%

1Y

71.4%

FAB

UK£0.066

Fusion Antibodies

7D

1.6%

1Y

72.4%

PRM

UK£0.033

Proteome Sciences

7D

-16.5%

1Y

-10.9%

DXRX

UK£1.38

Diaceutics

7D

-1.1%

1Y

3.4%

ONT

UK£1.24

Oxford Nanopore Technologies

7D

-0.3%

1Y

18.1%

HVO

UK£0.16

hVIVO

7D

-7.0%

1Y

-40.7%

OBD

UK£0.0031

Oxford BioDynamics

7D

-4.0%

1Y

-96.0%

MXCT

UK£1.66

MaxCyte

7D

-2.6%

1Y

-55.9%

PYC

UK£0.004

Physiomics

7D

-3.6%

1Y

-68.8%